References
- Krol N, Spies TH, van Balen J, Hartman J, Wensing M, Grol R. Managing dyspepsia in general practice; an observational study. Quality in Primary Care 2003;11:173–80.
- Bodger K, Daly MJ, Heatley RV. Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners. Aliment Pharmacol Ther 1996;10:889–95.
- Stichting farmaceutische kengetallen. Omzet top 10 genees-middelen. 2000, Data en Feiten Selectie. Den Haag, 2001.
- Quartero AO, Smeets HM, de Wit NJ. Trends and determinants of pharmacotherapy for dyspepsia: analysis of 3-year prescription data in The Netherlands. Scand J Gastroenterol 2003;38: 676–7.
- Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998;317:452–6.
- Grime J, Pollock K, Blenkinsopp A. Proton pump inhibi-tors: perspectives of patients and their GPs. Br J Gen Pract 2001;51:703–11.
- Hungin AP, Rubin GP, O'Flanagan H. Long-term prescrib-ing of proton pump inhibitors in general practice. Br J Gen Pract 1999;49:451–3.
- Hungin AP, Rubin GP, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999;49:463–4.
- Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self regulation of treatment may be an under-exploited resource. Soc Sci Med 2000;51:1827–39.
- Numans ME, de Wit NJ, Geerdes RHM, Muris JWM, Starmans R, Postema PhJ, et al. NHG-Standaard Maagk-lachten (eerste herziening) [Dutch College of General Practitioners Guideline Dyspepsia, first revision]. Huisarts Wet 1996;39:565–77.
- Numans ME, De Wit NJ, Dirven JAM, Hurenkamp GJB, Meijer QCM, Muris JWM, et al. NHG-standaard Maagk-lachten (tweede herziening) [Dutch College of General Practitioners Guideline Dyspepsia, second revision]. Hui-sarts Wet 2003;46:690–700.
- Hunt RH. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use [editorial]. CMAJ 1996;154:49–53.
- Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810–6.
- Stevenson A, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000;50:829–40.
- Makoul G, Arntson P, Schofield T. Health promotion in primary care: physician-patient communication and deci-sion making about prescription medications. Soc Sci Med 1995;41:1241–54.
- Krol N, Weijnen CF, Numans ME, Wensing M, Grol R. General practitioners reflect on treatment of patients with dyspepsia; a qualitative interview study. Submitted 2004.
- Van der Kuy A, red. Farmacotherapeutisch Kompas 2000/ 2001. Amstelveen: College voor Zorgverzekeringen, com-missie farmaceutische hulp, 2000.
- Veldhuyzen-van-Zanten SJ, Tytgat KM, Pollak PT, Goldie J, Goodacre RL, Riddell RH, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993;46:273–9.
- Zee KI vd, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: Een handleiding. [Measurement of general health with the RAND-36: A manual]. 1st ed. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1993.
- Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antago-nists. Am J Gastroenterol 2001;96: 673–6.
- Sihvo S, Hemminki E. Self-medication of dyspepsia: How appropriate is it? Scand J Gastroenterol 1997;32:855–61.
- Kalish SC, Bohn RL, Avorn J. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Med Care 1997;35: 32–48.
- Dent J, Brun A, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999;44(Suppl 2):S1–S16.
- Scottish Intercollegiate Guidelines Network (SIGN). Dys-pepsia. A national clinical guideline. Publication no. 68. Edinburgh: SIGN, 2003.
- Hurenkamp GJ, Grundmeijer HG, Bindels PJ, Tytgat GN, van der Hu1st RW. Chronisch gebruik van maagzuursecre-tieremmende medicatie in de huisartsenpraktijk in de regio Amsterdam [Chronic use of stomach acid inhibitor medica-tion in family practice in the region of Amsterdam]. Ned Tijdsch Geneeskd 1999;143:410–3.
- Barry CA, Bradley CP, Britten N, Stevenson A, Barber N. Patients' unvoiced agenda in general practice consultations: qualitative study. BMJ 2000;320:1246–50.